ArticleJournal of hematology & oncology2013

Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines.

Cornel Joseph Phillip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.